glucuronic acid has been researched along with Spinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aboka, AM; Georgescu, H; Gilbertson, LG; Kang, JD; Sowa, G; Studer, RK; Vo, N | 1 |
| Ghosh, P; Latham, J; Melrose, J; Moore, R; Taylor, TK | 1 |
2 other study(ies) available for glucuronic acid and Spinal Diseases
| Article | Year |
|---|---|
p38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration.
Topics: Adult; Alginates; Cell Culture Techniques; Cells, Cultured; Culture Media, Conditioned; Dinoprostone; Female; Glucuronic Acid; Hexuronic Acids; Humans; Imidazoles; Interleukin-1beta; Intervertebral Disc; Male; Matrix Metalloproteinase 3; Middle Aged; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Signal Transduction; Spinal Diseases; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha | 2007 |
Topographical variation in the catabolism of aggrecan in an ovine annular lesion model of experimental disc degeneration.
Topics: Aggrecans; Alginates; Animals; Blotting, Western; Cells, Cultured; Chondroitin Sulfate Proteoglycans; Chromatography, Gel; Culture Media; Extracellular Matrix Proteins; Female; Glucuronic Acid; Hexuronic Acids; Intervertebral Disc; Lectins, C-Type; Microspheres; Peptide Fragments; Proteoglycans; Sheep; Spinal Diseases | 1997 |